Strengthening Families & Communities, LLC
Position in VKTX — Viking Therapeutics, Inc.
CIK 1921196
BOSTON, MA
Position in VKTX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$4,881
-$396 QoQ
Shares Held
150
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Strengthening Families & Communities, LLC holds $172,945 across 11 Biotechnology names. VKTX ranks #6 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGON |
CG Oncology, Inc.
|
1,000 | $67,680 | |
| 2 | ACLX |
Arcellx, Inc.
|
500 | $57,410 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
24 | $18,543 | |
| 4 | VTVT |
vTv Therapeutics Inc.
|
173 | $6,861 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
13 | $5,805 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
This page
|
150 | $4,881 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
79 | $4,462 | |
| 8 | CRSP |
CRISPR Therapeutics AG
|
60 | $2,854 |
All Filings in VKTX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,881 | 150 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,277 | 150 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||